Physician profile
Pritham P Reddy
NPI 1134332919
$3,497.29
in general payments reported to CMS, 2019-2025
33 companies · $531 in 2025
The $531 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $177 · 2021: $510 · 2022: $446 · 2023: $559 · 2024: $863 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,952.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,755.59 | 2021-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Silk Road Medical, INC. | $296.64 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $142.76 | 2021-2024 | Supera |
| Angiodynamics, INC. | $127.73 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Smith+Nephew, INC. | $112.58 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $99.56 | 2019-2021 | |
| Bolton Medical INC | $78.38 | 2019-2024 | Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $77.08 | 2021-2022 | |
| Imperative Care, INC | $75.08 | 2025 | Prodigy Catheter |
| W. L. Gore & Associates, INC. | $71.20 | 2019-2020 | |
| Acera Surgical, INC. | $59.48 | 2024-2025 | Restrata Wound Matrix |
| Inari Medical, INC. | $54.88 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Organogenesis INC. | $53.57 | 2021 | |
| Getinge USA Sales, LLC | $47.99 | 2020-2021 | |
| Covidien LP | $46.52 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $38.36 | 2023 | Gemtesa |
| Janssen Biotech, INC. | $35.85 | 2025 | Tremfya |
| Boston Scientific Corporation | $34.49 | 2021 | |
| Kerecis Limited | $30.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Shockwave Medical, INC | $29.69 | 2025 | |
| Penumbra, INC. | $26.24 | 2020 | |
| Cardiovascular Systems INC. | $25.69 | 2019 | |
| Cordis US Corp. | $24.89 | 2025 | Mynx Control |
| Acell, INC. | $24.84 | 2019 | |
| Ekos Corporation | $21.02 | 2019 | |
| Solventum Corporation | $16.00 | 2025 | Prevena |
| Abbvie INC. | $14.48 | 2023 | |
| Cardiva Medical, INC. | $14.21 | 2019 | |
| Medtronic, INC. | $13.46 | 2022 | |
| Next Science LLC | $13.09 | 2023 | Xperience, Blastx, Surgx |
| Cardinal Health 200 LLC | $12.93 | 2019 | |
| Avenu Medical INC. | $11.84 | 2020 | |
| Artivion, INC. | $10.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pritham Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.